@article{e60db623dc154de5802117338c2a3f15,
title = "No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness",
keywords = "CYP2D6, severe mental illness (SMI), guidelines, dose adjustment, genotyping, psychopharmacology, personalized medicine, CURACAO EXTRAPYRAMIDAL SYNDROMES, TARDIVE-DYSKINESIA, RATING-SCALE, PERSONALIZED MEDICINE, INDUCED AKATHISIA, SCHIZOPHRENIA, PHARMACOGENETICS, ANTIPSYCHOTICS, 2D6, POLYMORPHISMS",
author = "Koopmans, {Anne B.} and Vinkers, {David J.} and Poulina, {Igmar T.} and Gelan, {Petra J. A.} and {van Schaik}, {Ron H. N.} and Hoek, {Hans W.} and {van Harten}, {Peter N.}",
year = "2018",
month = aug,
day = "7",
doi = "10.3389/fpsyt.2018.00349",
language = "English",
volume = "9",
journal = "Frontiers in Psychiatry",
issn = "1664-0640",
publisher = "Frontiers Media S.A.",
}